NO930059L - O-GLYCOSYLERT IFN-ALFA - Google Patents
O-GLYCOSYLERT IFN-ALFAInfo
- Publication number
- NO930059L NO930059L NO93930059A NO930059A NO930059L NO 930059 L NO930059 L NO 930059L NO 93930059 A NO93930059 A NO 93930059A NO 930059 A NO930059 A NO 930059A NO 930059 L NO930059 L NO 930059L
- Authority
- NO
- Norway
- Prior art keywords
- ifn
- glycosylert
- alfa
- glycosylated
- alpha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
The objects of the invention are O-glycosylated IFN-alpha, a process for producing the same and the use of the O-glycosylated proteins as medicinal drugs.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19904021917 DE4021917A1 (en) | 1990-07-10 | 1990-07-10 | O-glycosylated alpha-interferon, used as medicament - isolated following secretion into conditioned medium of mammalian cells contg. a suitable expression plasmid |
DE19904035877 DE4035877A1 (en) | 1990-11-12 | 1990-11-12 | O-glycosylated alpha interferon |
PCT/EP1991/001266 WO1992001055A1 (en) | 1990-07-10 | 1991-07-06 | O-glycosylated ifn-alpha |
Publications (2)
Publication Number | Publication Date |
---|---|
NO930059L true NO930059L (en) | 1993-01-08 |
NO930059D0 NO930059D0 (en) | 1993-01-08 |
Family
ID=25894855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO930059A NO930059D0 (en) | 1990-07-10 | 1993-01-08 | O-GLYCOSYLERT IFN-ALFA |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0538300B1 (en) |
JP (1) | JPH06502987A (en) |
KR (1) | KR930701601A (en) |
AT (1) | ATE104348T1 (en) |
AU (1) | AU650893B2 (en) |
CA (1) | CA2084514A1 (en) |
CZ (1) | CZ386392A3 (en) |
DE (1) | DE59101397D1 (en) |
DK (1) | DK0538300T3 (en) |
ES (1) | ES2063515T3 (en) |
FI (1) | FI930058A0 (en) |
HU (1) | HUT65846A (en) |
NO (1) | NO930059D0 (en) |
PL (1) | PL297610A1 (en) |
SK (1) | SK386392A3 (en) |
WO (1) | WO1992001055A1 (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ245771A (en) * | 1992-02-07 | 1994-08-26 | New England Medical Center Inc | Mammalian gastrin/cholecystokinin b (cck-b) receptor and antagonists |
US5541071A (en) * | 1992-02-07 | 1996-07-30 | New England Medical Center Hospitals, Inc. | Assay for identifying antagonists of gastrin and CCK-B receptors |
EP0626448A3 (en) * | 1993-05-26 | 1998-01-14 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Process for preparing and purifying alpha-interferon |
WO1996013608A2 (en) * | 1994-10-28 | 1996-05-09 | Innogenetics N.V. | Polynucleic acid sequences for use in the detection and differentiation of prokaryotic organisms |
ATE253122T1 (en) * | 1996-08-14 | 2003-11-15 | Us Gov Health & Human Serv | POLYNUCLEOTIDE VACCINE VECTOR |
GB9904695D0 (en) * | 1999-03-01 | 1999-04-21 | Imp Cancer Res Tech | Peptide |
CA2405709A1 (en) | 2000-04-12 | 2001-10-25 | Human Genome Sciences, Inc. | Albumin fusion proteins |
US7214660B2 (en) | 2001-10-10 | 2007-05-08 | Neose Technologies, Inc. | Erythropoietin: remodeling and glycoconjugation of erythropoietin |
US7173003B2 (en) | 2001-10-10 | 2007-02-06 | Neose Technologies, Inc. | Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
EP2298354B1 (en) * | 2001-10-10 | 2014-03-19 | ratiopharm GmbH | Remodelling and glycoconjugation of interferon-beta |
CA2471363C (en) | 2001-12-21 | 2014-02-11 | Human Genome Sciences, Inc. | Albumin fusion proteins |
CA2519092C (en) | 2003-03-14 | 2014-08-05 | Neose Technologies, Inc. | Branched water-soluble polymers and their conjugates |
PL1615945T3 (en) | 2003-04-09 | 2012-03-30 | Ratiopharm Gmbh | Glycopegylation methods and proteins/peptides produced by the methods |
US8791070B2 (en) | 2003-04-09 | 2014-07-29 | Novo Nordisk A/S | Glycopegylated factor IX |
US9005625B2 (en) | 2003-07-25 | 2015-04-14 | Novo Nordisk A/S | Antibody toxin conjugates |
US8633157B2 (en) | 2003-11-24 | 2014-01-21 | Novo Nordisk A/S | Glycopegylated erythropoietin |
US20080305992A1 (en) | 2003-11-24 | 2008-12-11 | Neose Technologies, Inc. | Glycopegylated erythropoietin |
US20060040856A1 (en) | 2003-12-03 | 2006-02-23 | Neose Technologies, Inc. | Glycopegylated factor IX |
KR101439880B1 (en) | 2004-01-08 | 2014-09-12 | 라티오팜 게엠베하 | O-linked glycosylation of peptides |
EP1771066A2 (en) | 2004-07-13 | 2007-04-11 | Neose Technologies, Inc. | Branched peg remodeling and glycosylation of glucagon-like peptide-1 glp-1 |
EP1799249A2 (en) | 2004-09-10 | 2007-06-27 | Neose Technologies, Inc. | Glycopegylated interferon alpha |
WO2006050247A2 (en) | 2004-10-29 | 2006-05-11 | Neose Technologies, Inc. | Remodeling and glycopegylation of fibroblast growth factor (fgf) |
NZ556436A (en) | 2005-01-10 | 2010-11-26 | Biogenerix Ag | Glycopegylated granulocyte colony stimulating factor |
EP2386571B1 (en) | 2005-04-08 | 2016-06-01 | ratiopharm GmbH | Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
JP5216580B2 (en) | 2005-05-25 | 2013-06-19 | ノヴォ ノルディスク アー/エス | Glycopegylated factor IX |
US20070105755A1 (en) | 2005-10-26 | 2007-05-10 | Neose Technologies, Inc. | One pot desialylation and glycopegylation of therapeutic peptides |
US20090048440A1 (en) | 2005-11-03 | 2009-02-19 | Neose Technologies, Inc. | Nucleotide Sugar Purification Using Membranes |
AR078117A1 (en) | 2006-06-20 | 2011-10-19 | Protech Pharma S A | A RECOMBINANT MUTEIN OF THE GLICOSILATED HUMAN ALPHA INTERFERON, A CODIFYING GENE FOR SUCH MUTEIN, A METHOD OF PRODUCTION OF SUCH GENE, A METHOD FOR OBTAINING A EUCARIOTE CELL MANUFACTURING THIS MUTEINE, A METHOD FOR A MUTE DIFFERENT PROCEDURE |
ES2516694T3 (en) | 2006-07-21 | 2014-10-31 | Ratiopharm Gmbh | Glycosylation of peptides through glycosylation sequences with O-binding |
WO2008057683A2 (en) | 2006-10-03 | 2008-05-15 | Novo Nordisk A/S | Methods for the purification of polypeptide conjugates |
BRPI0809670A8 (en) | 2007-04-03 | 2018-12-18 | Biogenerix Ag | methods to increase stem cell production, to increase the number of granulocytes in an individual, to prevent, treat and alleviate myelosuppression that results from cancer therapy, to treat a condition in an individual, to treat neutropenia and thrombocytopenia in a mammal, to expand hematopoietic stem cells in culture, to increase hematopoiesis in an individual, to increase the number of hematopoietic progenitor cells in an individual, and to provide stable bone marrow graft, and, oral dosage form. |
CN101778859B (en) | 2007-06-12 | 2014-03-26 | 诺和诺德公司 | Improved process for the production of nucleotide sugars |
US8207112B2 (en) | 2007-08-29 | 2012-06-26 | Biogenerix Ag | Liquid formulation of G-CSF conjugate |
CN103497246B (en) | 2008-02-27 | 2016-08-10 | 诺沃—诺迪斯克有限公司 | The Factor VlII molecule puted together |
WO2014102103A2 (en) | 2012-12-31 | 2014-07-03 | Boehringer Ingelheim International Gmbh | Heterologous intron within a signal peptide |
WO2014102101A1 (en) | 2012-12-31 | 2014-07-03 | Boehringer Ingelheim International Gmbh | Novel intron sequences |
RU2610173C1 (en) * | 2016-03-30 | 2017-02-08 | Илья Александрович Марков | Recombinant plasmid pfm-ifn-17 providing expression of interferon alpha-2b of human, recombinant plasmid pfm-ap, providing expression of enzyme methionine-aminopeptidase e coli, biplasmid strain escherichia coli fm-ifn-ap (pfm-ifn-17, pfm-ap) - producer (met-) of recombinant interferon alpha -2b of human |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN150740B (en) * | 1978-11-24 | 1982-12-04 | Hoffmann La Roche | |
WO1983000693A1 (en) * | 1981-08-14 | 1983-03-03 | Berg, Kurt, Frimann | SUBJECTS RELATING TO HUMAN INTEFERON-'alpha' SUBTYPE PROTEINS AND CORRESPONDING ANTIBODIES |
DE3306060A1 (en) * | 1983-02-22 | 1984-08-23 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | NEW IMMUNGLOBULIN-PRODUCING HYBRID CELL LINES, THEIR USE AND METHOD FOR THE PRODUCTION THEREOF |
FR2560212B1 (en) * | 1984-02-24 | 1989-12-29 | Unicet | MONOCLONAL ANTIBODIES AGAINST INTERFERON A2 AND HYBRIDOMAS PRODUCING SUCH ANTIBODIES |
-
1991
- 1991-07-06 DK DK91912306.7T patent/DK0538300T3/en active
- 1991-07-06 AT AT91912306T patent/ATE104348T1/en not_active IP Right Cessation
- 1991-07-06 DE DE59101397T patent/DE59101397D1/en not_active Expired - Fee Related
- 1991-07-06 PL PL29761091A patent/PL297610A1/xx unknown
- 1991-07-06 JP JP3511638A patent/JPH06502987A/en active Pending
- 1991-07-06 WO PCT/EP1991/001266 patent/WO1992001055A1/en not_active Application Discontinuation
- 1991-07-06 KR KR1019930700049A patent/KR930701601A/en not_active Application Discontinuation
- 1991-07-06 ES ES91912306T patent/ES2063515T3/en not_active Expired - Lifetime
- 1991-07-06 HU HU9300036A patent/HUT65846A/en unknown
- 1991-07-06 EP EP91912306A patent/EP0538300B1/en not_active Expired - Lifetime
- 1991-07-06 CA CA002084514A patent/CA2084514A1/en not_active Abandoned
- 1991-07-06 SK SK3863-92A patent/SK386392A3/en unknown
- 1991-07-06 AU AU82082/91A patent/AU650893B2/en not_active Ceased
-
1992
- 1992-12-23 CZ CS923863A patent/CZ386392A3/en unknown
-
1993
- 1993-01-08 FI FI930058A patent/FI930058A0/en not_active Application Discontinuation
- 1993-01-08 NO NO930059A patent/NO930059D0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU650893B2 (en) | 1994-07-07 |
CA2084514A1 (en) | 1992-01-11 |
DE59101397D1 (en) | 1994-05-19 |
DK0538300T3 (en) | 1994-10-10 |
HUT65846A (en) | 1994-07-28 |
ES2063515T3 (en) | 1995-01-01 |
WO1992001055A1 (en) | 1992-01-23 |
FI930058A (en) | 1993-01-08 |
EP0538300B1 (en) | 1994-04-13 |
AU8208291A (en) | 1992-02-04 |
KR930701601A (en) | 1993-06-12 |
ATE104348T1 (en) | 1994-04-15 |
SK386392A3 (en) | 1994-08-10 |
JPH06502987A (en) | 1994-04-07 |
NO930059D0 (en) | 1993-01-08 |
HU9300036D0 (en) | 1993-04-28 |
EP0538300A1 (en) | 1993-04-28 |
CZ386392A3 (en) | 1993-08-11 |
PL297610A1 (en) | 1992-07-13 |
FI930058A0 (en) | 1993-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE104348T1 (en) | O-GLYCOSYLATED IFN-ALPHA. | |
ID28003A (en) | ADAMANTANA'S DEMONS | |
NO307968B1 (en) | Pyrazolo- and pyrrolopyridines and pharmaceutical mixtures thereof | |
FI915826A (en) | PHARMACEUTICAL AEMNEN. | |
ES2036737T3 (en) | PROCEDURE FOR OBTAINING PHARMACEUTICAL MIXTURES. | |
DE69013684D1 (en) | KNEE PROSTHESIS. | |
IT9047580A0 (en) | PROCEDURE FOR THE TREATMENT OF INORGANIC POWDERS. | |
ITRM920237A1 (en) | IMPROVED USE OF BRONCODILATORY MEDICINAL PRODUCTS B2. | |
DE3882593T2 (en) | Polypeptide and its production. | |
DK0540609T3 (en) | Cephalosporins and homologs, preparations and pharmaceutical preparations | |
DE58908155D1 (en) | ENDOPROTHESIS OF THE HIP JOINT. | |
NO912825L (en) | PROCEDURE FOR THE PREPARATION OF COCONJUGATE VACCINES INCLUDING IM MUNOGENT PROTEIN, HIV RELATED PEPTIDES AND ANIONIC GROUPS. | |
NO911429L (en) | DRUG TREATMENT. | |
NO913360L (en) | PROCEDURE FOR THE PREPARATION OF SYNTHESIC GAS. | |
ATE137487T1 (en) | COMPLEXES CONTAINING S(+)-PHENYL-ALKANOIC ACIDS AND ALPHA-HYDROXY-ALKANOIC ACIDS | |
NO891574D0 (en) | PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL USES. | |
NO892716L (en) | PROCEDURE FOR PRODUCING PROTEINS. | |
IT9048026A0 (en) | PHARMACEUTICAL AND/OR COSMETIC PREPARATION. | |
FR2631230B1 (en) | FOLDABLE BED, ESPECIALLY FOR MEDICAL APPLICATIONS | |
NO891941D0 (en) | PROCEDURE FOR THE MANUFACTURE OF CYCLOAL CADIANS. | |
MX9203129A (en) | BMP-5 PROTEINS. | |
SE9002274D0 (en) | NOVEL 3,3'-DITHIOBIS (PROPIONIC ESTERS). | |
NO871013L (en) | PHARMACEUTICAL ARTICLE AND PROCEDURE FOR PREPARING THEREOF. | |
ATE92106T1 (en) | POLYPEPTIDE AND ITS PRODUCTION. |